JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
LGND Financials - Ligand Pharmaceuticals Income & Cash Flow | Ledgeburg
LGND - Ligand Pharmaceuticals Inc.
USD | NASDAQ | Healthcare
Summary
Summary LGND Stock
Financials
Financials LGND Stock
Loading...
Loading...
Income Statement
Income Statement LGND Stock
Balance Sheet
Balance Sheet LGND Stock
Cash Flow Statement
Cash Flow Statement LGND Stock
Loading...
Loading...
Home
Stocks
Ligand Pharmaceuticals Inc. (LGND)
Financials
Financials of LGND
Loading...
Loading...
Loading...
Loading...
Revenue
$268.087M
Operating Income
$41.002M
Net Income
$124.453M
Share Count (Basic)
19.338M
Operating Cash Flow
$49.359M
Free Cash Flow
$48.907M
Cash And Short-Term Equivalents
$733.521M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
50M
100M
150M
200M
250M
FY2021
FY2022
FY2023
Revenue $USD
0
20M
40M
60M
80M
100M
120M
Q1 FY25
Q2 FY25
Annual
Quarterly
Net Income $USD
0
50M
100M
FY2021
Annual
Quarterly
Margins
Gross
Operating
Net
-20%
0%
20%
40%
FY2024
FY2025
Q3 FY25
Q4 FY25
Q1 FY26
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-50M
0
50M
100M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-100%
-50%
0%
50%
100%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26